Has Alireza Sedarat, MD received payments from drug or device companies?

Yes. Drug and device makers reported $105,184 in general payments to Alireza Sedarat, MD across 250 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alireza Sedarat, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alireza Sedarat, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alireza Sedarat, MD

Gastroenterology · Santa Monica, CANPI 1629133913

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 70.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $43,240 and has fallen 50.2% since, to $21,554 in 2025. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,184in general payments, 2019–2025

Across 250 payments — averaging $420.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$75K
US Endoscopy$14K
Fujifilm Healthcare Americas Corporation$8K
Steris Corporation$3K
Apollo Endosurgery US Inc$1K
Olympus America Inc.$626
plus $3K from 10 others

What the payments were for

Consulting fees$49,77147%
Speaking & faculty fees$31,50030%
Travel & lodging$8,0168%
Food & beverage$15,89715%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	154	$74,524
US Endoscopy	6	$14,250
Fujifilm Healthcare Americas Corporation	23	$8,286
Steris Corporation	18	$3,483
Apollo Endosurgery US Inc	7	$1,106
Olympus America Inc.	6	$626
Conmed Corporation	12	$601
Endogastric Solutions, Inc	7	$481
Cook Medical LLC	6	$480
ERBE USA Inc	2	$388
Galvanize Therapeutics, Inc	1	$243
Pentax Of America, Inc.	2	$195
Micro-tech Endoscopy USA, Inc.	3	$192
Ipsen Biopharmaceuticals, Inc	1	$134
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$100
Madrigal Pharmaceuticals	1	$98

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$17,044
TRUFREEZE$9,853
FUJIFILM$8,103
RESOLUTION CLIP$7,702
Resolution 360 Clip$5,151
GENERAL ENDOCHOICE$1,887
GENERAL - BILIARY DEVICES$1,601
EXALT Model D$1,548
OverStitch Endoscopic Suturing System$848
X-Tack Endoscopic HeliX Tacking System$795
ORISE$705
OverStitch Endoscopic Suturing System Sx$450
ESOPHYX$360
SPYGLASS$330
CONMED BILIARY$322
ORBERA Intragastric Balloon System$270
VIO3$255
EchoTip$245
ALIYA SYSTEM$243
AUTOTOME$213

How this compares

$105,184 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024

$210,383

Medicare patients

496

Services billed

1,325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sucralfate	17	$2,173
Pantoprazole Sodium	57	$770
Omeprazole	28	$498
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	18	$357

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Santa Monica

Bennett RothLos Angeles$2.8M
Douglas NguyenMission Viejo$2M
Sammy SaabLos Angeles$1.9M
Kenneth ChangNewport Beach$1.3M
Joo HwangStanford$1M
Drew SchembreWalnut Creek$659K
Quan Nhula Jolla$641K
Sadeea AbbasiLos Angeles$556K
Ali RezaieWest Hollywood$519K
Kenneth BinmoellerSan Francisco$507K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →